APT Medical Inc.
SHH: 688617.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Zhenghui Cheng
- Employees
- 2,155
- Headquarters
- Shenzhen, China
- IPO year
- 2021
- Market cap
- CN¥32.8B
- Website
- https://www.aptmed.com
Loading 688617…
Loading profile data…Frequently asked questions about 688617
What does APT Medical Inc. (688617.SS) do?
APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such...
Where does 688617.SS trade?
APT Medical Inc. (688617.SS) trades on the Shanghai Stock Exchange.
What sector is 688617.SS in?
APT Medical Inc. (688617.SS) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of APT Medical Inc.?
Zhenghui Cheng is the chief executive officer of APT Medical Inc. (688617.SS).
Where is APT Medical Inc. headquartered?
APT Medical Inc. is headquartered in China.
Does 688617.SS pay a dividend?
Yes — APT Medical Inc. (688617.SS) paid a trailing twelve-month dividend of CNY 1.21 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 688617.SS go public?
APT Medical Inc. (688617.SS) completed its initial public offering in 2021.